Physiological levels of estradiol limit murine osteoarthritis progression

Among patients with knee osteoarthritis (OA), postmenopausal women are over-represented. The purpose of this study was to determine whether deficiency of female sex steroids affects OA progression and to evaluate the protective effect of treatment with a physiological dose of 17β-estradiol (E2) on OA progression using a murine model. Ovariectomy (OVX) of female mice was used to mimic a postmenopausal state. OVX or sham-operated mice underwent surgery for destabilization of the medial meniscus (DMM) to induce OA. E2 was administered in a pulsed manner for 2 and 8 weeks. OVX of OA mice did not influence the cartilage phenotype or synovial thickness, while both cortical and trabecular subchondral bone mineral density (BMD) decreased after OVX compared with sham-operated mice at 8 weeks post-DMM surgery. Additionally, OVX mice displayed decreased motor activity, reduced threshold of pain sensitivity, and increased number of T cells in the inguinal lymph nodes compared to sham-operated mice 2 weeks after OA induction. Eight weeks of treatment with E2 prevented cartilage damage and thickening of the synovium in OVX OA mice. The motor activity was improved after E2 replacement at the 2 weeks time point, which was also associated with lower pain sensitivity in the OA paw. E2 treatment protected against OVX-induced loss of subchondral trabecular bone. The number of T cells in the inguinal lymph nodes was reduced by E2 treatment after 8 weeks. This study demonstrates that treatment with a physiological dose of E2 exerts a protective role by reducing OA symptoms.

[1]  M. Poutanen,et al.  Low Progesterone and Low Estradiol Levels Associate With Abdominal Aortic Aneurysms in Men , 2021, The Journal of clinical endocrinology and metabolism.

[2]  M. Lagerquist,et al.  Pulsed administration for physiological estrogen replacement in mice , 2021, F1000Research.

[3]  H. Hwang,et al.  Comparison of joint degeneration and pain in male and female mice in DMM model of osteoarthritis. , 2021, Osteoarthritis and cartilage.

[4]  N. Sadana,et al.  Estrogen receptors in pain modulation: cellular signaling , 2021, Biology of sex differences.

[5]  N. Emmanuelle,et al.  Critical Role of Estrogens on Bone Homeostasis in Both Male and Female: From Physiology to Medical Implications. , 2021, International journal of molecular sciences.

[6]  Jianlin Zuo,et al.  Estrogen-related receptors: novel potential regulators of osteoarthritis pathogenesis , 2021, Molecular medicine.

[7]  T. Vincent.  Of mice and men: converging on a common molecular understanding of osteoarthritis , 2020, The Lancet Rheumatology.

[8]  M. Lamghari,et al.  Nociceptive mechanisms driving pain in a post-traumatic osteoarthritis mouse model , 2020, Scientific Reports.

[9]  G. Hawker.  Osteoarthritis is a serious disease. , 2019, Clinical and experimental rheumatology.

[10]  Qing Jiang,et al.  Estrogen prevents articular cartilage destruction in a mouse model of AMPK deficiency via ERK-mTOR pathway. , 2019, Annals of translational medicine.

[11]  Li Duan,et al.  Estrogen Modulates Cartilage and Subchondral Bone Remodeling in an Ovariectomized Rat Model of Postmenopausal Osteoarthritis , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[12]  E. Spangenburg,et al.  Effects of ovarian hormones and estrogen receptor α on physical activity and skeletal muscle fatigue in female mice , 2019, Experimental Gerontology.

[13]  M. H. van den Bosch,et al.  Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease? , 2018, Clinical and experimental immunology.

[14]  Joo Hyun Park,et al.  Association between bone mineral density and knee osteoarthritis in Koreans: the Fourth and Fifth Korea National Health and Nutrition Examination Surveys. , 2018, Osteoarthritis and cartilage.

[15]  A. Nelson.  Osteoarthritis year in review 2017: clinical. , 2017, Osteoarthritis and cartilage.

[16]  M. Akagi,et al.  Plasminogen activator inhibitor-1 deficiency enhances subchondral osteopenia after induction of osteoarthritis in mice , 2017, BMC Musculoskeletal Disorders.

[17]  R. H. Scofield,et al.  Menopause and Rheumatic Disease. , 2017, Rheumatic diseases clinics of North America.

[18]  C. Scanzello.  Role of low-grade inflammation in osteoarthritis , 2017, Current opinion in rheumatology.

[19]  R. Reantragoon,et al.  Immune Mediators in Osteoarthritis: Infrapatellar Fat Pad-Infiltrating CD8+ T Cells Are Increased in Osteoarthritic Patients with Higher Clinical Radiographic Grading , 2016, International journal of rheumatology.

[20]  S. Goldring,et al.  Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage–bone crosstalk , 2016, Nature Reviews Rheumatology.

[21]  Qian Wang,et al.  Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis , 2016, Nature Reviews Rheumatology.

[22]  T. H. Haut Donahue,et al.  Assessment of cortical and trabecular bone changes in two models of post‐traumatic osteoarthritis , 2015, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[23]  M. Lagerquist,et al.  Sex steroid actions in male bone. , 2014, Endocrine reviews.

[24]  D. Hunter,et al.  The epidemiology of osteoarthritis. , 2014, Best practice & research. Clinical rheumatology.

[25]  Daniel Prieto-Alhambra,et al.  Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints , 2013, Annals of the rheumatic diseases.

[26]  Changqing Zhang,et al.  Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes , 2013, Arthritis Research & Therapy.

[27]  Richard J. Miller,et al.  CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis , 2012, Proceedings of the National Academy of Sciences.

[28]  S. Khosla,et al.  Estrogen and the skeleton , 2012, Trends in Endocrinology & Metabolism.

[29]  S. Goldring,et al.  Osteoarthritis: a disease of the joint as an organ. , 2012, Arthritis and rheumatism.

[30]  M. Wiles,et al.  Mouse Estrous Cycle Identification Tool and Images , 2012, PloS one.

[31]  C. Little,et al.  The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. , 2010, Osteoarthritis and cartilage.

[32]  H. Weinans,et al.  Estrogen modulates iodoacetate‐induced gene expression in bovine cartilage explants , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[33]  G. Herrero-Beaumont,et al.  Osteoarthritis associated with estrogen deficiency , 2009, Arthritis research & therapy.

[34]  J. V. van Meurs,et al.  No clear association between female hormonal aspects and osteoarthritis of the hand, hip and knee: a systematic review. , 2009, Rheumatology.

[35]  R. Sanoja,et al.  Estrogen modulation of ovariectomy‐induced hyperalgesia in adult mice , 2008, European journal of pain.

[36]  H Weinans,et al.  Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment - a systematic approach. , 2008, Osteoarthritis and cartilage.

[37]  R. Straub,et al.  The complex role of estrogens in inflammation. , 2007, Endocrine reviews.

[38]  S. Glasson,et al.  Osteoarthritis severity is sex dependent in a surgical mouse model. , 2007, Osteoarthritis and cartilage.

[39]  D. Lowe,et al.  Estradiol and tamoxifen reverse ovariectomy-induced physical inactivity in mice. , 2007, Medicine and science in sports and exercise.

[40]  R. Straub,et al.  Quantitative determination of steroid hormone receptor positive cells in the synovium of patients with rheumatoid arthritis and osteoarthritis: is there a link to inflammation? , 2006, Annals of the rheumatic diseases.

[41]  B. Riggs,et al.  Dose-response of estrogen on bone versus the uterus in ovariectomized mice. , 2004, European journal of endocrinology.

[42]  C. Christiansen,et al.  Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM) , 2004, Menopause.

[43]  A. Gils,et al.  Plasminogen activator inhibitor-1. , 2004, Current medicinal chemistry.

[44]  L. Tankó,et al.  Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application , 2004, Arthritis research & therapy.

[45]  K. Hargreaves,et al.  The effects of pregnancy and estrogen on the expression of calcitonin gene-related peptide (CGRP) in the uterine cervix, dorsal root ganglia and spinal cord , 2003, Peptides.

[46]  R. Pacifici,et al.  Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Pacifici,et al.  Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. , 2000, The Journal of clinical investigation.

[48]  K. Messner,et al.  Articular cartilage compressive stiffness following oophorectomy or treatment with 17β‐estradiol in young postpubertal rabbits , 1999, Acta obstetricia et gynecologica Scandinavica.

[49]  K A Athanasiou,et al.  Biochemical effects of estrogen on articular cartilage in ovariectomized sheep. , 1997, Osteoarthritis and cartilage.